PhotoBiotics Sitemap
About Us
Technology / Pipeline
- Targeting platform – 'OptiLink'
- Light activated cancer therapy – 'ProstaLite'
- MRI contrast agents & imaging
- Photosensitiser innovations
- Additional products and applications
- PDT & Cancer
Investors / Partnering
News / Media
Contact Us
News Archive
Press Releases
- PhotoBiotics' COO presents at major Antibody Drug Conjugate (ADC) conference in Barcelona
- PhotoBiotics presents OptiLinkTM Antibody-drug conjugate (ADC) platform at World ADC Summit in San Francisco
- PhotoBiotics Raises Further Funding for Antibody Drug Conjugates (ADCs)
- PhotoBiotics' CSO hosts Antibody Drug Conjugate (ADC) event at Berlin Novel Protein Therapeutics Conference